4//SEC Filing
Wilfong Diane E. 4
Accession 0001127602-23-002284
CIK 0000882095other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 3:37 PM ET
Size
8.4 KB
Accession
0001127602-23-002284
Insider Transaction Report
Form 4
Wilfong Diane E
Interim Corp Controller & CAO
Transactions
- Award
Common Stock
2023-01-24+1,784→ 27,855 total - Tax Payment
Common Stock
2023-01-24$84.02/sh−1,244$104,521→ 30,711 total - Award
Common Stock
2023-01-24+4,100→ 31,955 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2021 and March 10, 2022. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until the requisite continuing service requirements are also met.
- [F2]Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on March 10, 2020. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001374988
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 3:37 PM ET
- Size
- 8.4 KB